Igc Pharma Inc
(IGC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 03-2017 | 03-2016 | |
| Sales | 4,072 | 5,116 | 2,193 | 580 | 6,367 |
| Cost of Goods | 3,957 | 4,984 | 2,111 | 362 | 5,523 |
| Gross Profit | 115 | 132 | 82 | 218 | 843 |
| Operating Expenses | 7,936 | 5,759 | 1,982 | 2,635 | 4,272 |
| Operating Income | -6,864 | -4,643 | -1,789 | -2,054 | -2,906 |
| Interest Expense | 0 | 0 | 0 | 0 | 214 |
| Other Income | -451 | 548 | 3 | 216 | 286 |
| Pre-tax Income | -7,315 | -4,095 | -1,786 | -1,838 | -2,833 |
| Income Tax | 0 | 2 | 0 | 14 | 1 |
| Net Income Continuous | -7,315 | -4,097 | -1,786 | -1,853 | -2,834 |
| Minority Interests | N/A | N/A | N/A | 14 | -26 |
| Net Income | $-7,315 | $-4,097 | $-1,786 | $-1,867 | $-2,808 |
| EPS Basic Total Ops | -0.19 | -0.13 | -0.06 | -0.07 | -0.17 |
| EPS Basic Continuous Ops | -0.19 | -0.12 | -0.06 | -0.07 | -0.17 |
| EPS Diluted Total Ops | -0.19 | -0.13 | -0.06 | -0.07 | -0.17 |
| EPS Diluted Continuous Ops | -0.19 | -0.12 | -0.06 | -0.07 | -0.17 |
| EPS Diluted Before Non-Recurring Items | -0.17 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-6,720 | $-4,584 | $-1,770 | $-1,658 | $-2,177 |